Pan-tumor genomic biomarkers for personalization of PD-1 checkpoint blockade based immunotherapy
收藏NIAID Data Ecosystem2026-05-26 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP149157
下载链接
链接失效反馈官方服务：
资源简介：
Tumor mutation burden (TMB) and a T-cell-inflamed gene expression profile (GEP) independently predict clinical outcome in pembrolizumab-treated patients in 22 indications and stratify distinct targets of resistance biology.
创建时间：
2018-10-09
